Unknown

Dataset Information

0

Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016-17 and 2017-18).

ABSTRACT: Introduction:Influenza A(H3N2) viruses predominated in Europe in 2016-17. In 2017-18 A(H3N2) and A(H1N1)pdm09 viruses co-circulated. The A(H3N2) vaccine component was the same in both seasons; while the A(H1N1)pdm09 component changed in 2017-18. In both seasons, vaccine seed A(H3N2) viruses developed adaptations/alterations during propagation in eggs, impacting antigenicity. Methods:We used the test-negative design in a multicentre primary care case-control study in 12 European countries to measure 2016-17 and 2017-18 influenza vaccine effectiveness (VE) against laboratory-confirmed influenza A(H1N1)pdm09 and A(H3N2) overall and by age group. Results:During the 2017-18 season, the overall VE against influenza A(H1N1)pdm09 was 59% (95% CI: 47-69). Among those aged 0-14, 15-64 and ≥65 years, VE against A(H1N1)pdm09 was 64% (95% CI: 37-79), 50% (95% CI: 28-66) and 66% (95% CI: 42-80), respectively. Overall VE against influenza A(H3N2) was 28% (95% CI: 17-38) in 2016-17 and 13% (95% CI: -15 to 34) in 2017-18. Among 0-14-year-olds VE against A(H3N2) was 28% (95%CI: -10 to 53) and 29% (95% CI: -87 to 73), among 15-64-year-olds 34% (95% CI: 18-46) and 33% (95% CI: -3 to 56) and among those aged ≥65 years 15% (95% CI: -10 to 34) and -9% (95% CI: -74 to 32) in 2016-17 and 2017-18, respectively. Conclusions:Our study suggests the new A(H1N1)pdm09 vaccine component conferred good protection against circulating strains, while VE against A(H3N2) was <35% in 2016-17 and 2017-18. The egg propagation derived antigenic mismatch of the vaccine seed virus with circulating strains may have contributed to this low effectiveness. A(H3N2) seed viruses for vaccines in subsequent seasons may be subject to the same adaptations; in years with lower than expected VE, recommendations of preventive measures other than vaccination should be given in a timely manner.

SUBMITTER: Kissling E 

PROVIDER: S-EPMC6807025 | biostudies-other | 2019 Dec

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016-17 and 2017-18).

Kissling Esther E   Pozo Francisco F   Buda Silke S   Vilcu Ana-Maria AM   Rizzo Caterina C   Gherasim Alin A   Horváth Judit Krisztina JK   Brytting Mia M   Domegan Lisa L   Meijer Adam A   Paradowska-Stankiewicz Iwona I   Machado Ausenda A   Vučina Vesna Višekruna VV   Lazar Mihaela M   Johansen Kari K   Dürrwald Ralf R   van der Werf Sylvie S   Bella Antonino A   Larrauri Amparo A   Ferenczi Annamária A   Zakikhany Katherina K   O'Donnell Joan J   Dijkstra Frederika F   Bogusz Joanna J   Guiomar Raquel R   Filipović Sanja Kurečić SK   Pitigoi Daniela D   Penttinen Pasi P   Valenciano Marta M  

Vaccine: X 20190917

<h4>Introduction</h4>Influenza A(H3N2) viruses predominated in Europe in 2016-17. In 2017-18 A(H3N2) and A(H1N1)pdm09 viruses co-circulated. The A(H3N2) vaccine component was the same in both seasons; while the A(H1N1)pdm09 component changed in 2017-18. In both seasons, vaccine seed A(H3N2) viruses developed adaptations/alterations during propagation in eggs, impacting antigenicity.<h4>Methods</h4>We used the test-negative design in a multicentre primary care case-control study in 12 European co  ...[more]

Similar Datasets

Unknown Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons.
| S-EPMC6331099 | biostudies-literature
Unknown Genetic and antigenic characterisation of influenza A(H3N2) viruses isolated in Yokohama during the 2016/17 and 2017/18 influenza seasons.
| S-EPMC6373070 | biostudies-literature
Unknown Estimating the burden of A(H1N1)pdm09 influenza in Finland during two seasons.
| S-EPMC4097990 | biostudies-literature
Unknown Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses.
| S-EPMC4594909 | biostudies-literature
Unknown Household transmission of influenza A(H1N1)pdm09 in the pandemic and post-pandemic seasons.
| S-EPMC4177918 | biostudies-literature
Unknown Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.
| S-EPMC7182608 | biostudies-literature
Unknown Molecular features of influenza A (H1N1)pdm09 prevalent in Mexico during winter seasons 2012-2014.
| S-EPMC5503254 | biostudies-literature
Unknown Effectiveness of A(H1N1)pdm09 influenza vaccine in adults recommended for annual influenza vaccination.
| S-EPMC3688717 | biostudies-literature
Unknown Moderate influenza vaccine effectiveness against influenza A(H1N1)pdm09 virus and low effectiveness against A(H3N2) virus among older adults during 2013-2014 influenza season in Beijing, China.
| S-EPMC6037442 | biostudies-literature
Unknown Genome-Wide Analysis of Evolutionary Markers of Human Influenza A(H1N1)pdm09 and A(H3N2) Viruses May Guide Selection of Vaccine Strain Candidates.
| S-EPMC4700966 | biostudies-literature